Sight Sciences Stock Forecast, Price & News

-0.45 (-1.56 %)
(As of 09/16/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume431,452 shs
Average Volume285,463 shs
Market Capitalization$1.34 billion
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive SGHT News and Ratings via Email

Sign-up to receive the latest news and ratings for Sight Sciences and its competitors with MarketBeat's FREE daily newsletter.

Sight Sciences logo

About Sight Sciences

Sight Sciences Inc. is a medical device company. It focused on the development and commercialization of proprietary devises which target the underlying causes of prevalent eye diseases. Sight Sciences Inc. is based in MENLO PARK, Calif.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.80 out of 5 stars

Medical Sector

773rd out of 1,352 stocks

Surgical & Medical Instruments Industry

77th out of 123 stocks

Analyst Opinion: 3.4Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Sight Sciences (NASDAQ:SGHT) Frequently Asked Questions

Is Sight Sciences a buy right now?

4 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Sight Sciences in the last twelve months. There are currently 1 hold rating and 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Sight Sciences stock.
View analyst ratings for Sight Sciences
or view top-rated stocks.

What stocks does MarketBeat like better than Sight Sciences?

Wall Street analysts have given Sight Sciences a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Sight Sciences wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Sight Sciences?

Sight Sciences saw a increase in short interest in the month of August. As of August 31st, there was short interest totaling 577,500 shares, an increase of 104.5% from the August 15th total of 282,400 shares. Based on an average daily volume of 415,700 shares, the days-to-cover ratio is presently 1.4 days. Currently, 2.6% of the shares of the stock are short sold.
View Sight Sciences' Short Interest

When is Sight Sciences' next earnings date?

Sight Sciences is scheduled to release its next quarterly earnings announcement on Thursday, November 11th 2021.
View our earnings forecast for Sight Sciences

How were Sight Sciences' earnings last quarter?

Sight Sciences Inc (NASDAQ:SGHT) posted its earnings results on Thursday, August, 12th. The company reported ($1.83) earnings per share for the quarter, missing the consensus estimate of ($0.93) by $0.90. The company had revenue of $12.54 million for the quarter, compared to analysts' expectations of $12.46 million.
View Sight Sciences' earnings history

What guidance has Sight Sciences issued on next quarter's earnings?

Sight Sciences issued an update on its FY 2021 earnings guidance on Thursday, September, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $46 million-$48 million.

What price target have analysts set for SGHT?

4 analysts have issued 1 year target prices for Sight Sciences' stock. Their forecasts range from $41.00 to $46.00. On average, they anticipate Sight Sciences' share price to reach $44.00 in the next year. This suggests a possible upside of 55.4% from the stock's current price.
View analysts' price targets for Sight Sciences
or view top-rated stocks among Wall Street analysts.

Who are some of Sight Sciences' key competitors?

When did Sight Sciences IPO?

(SGHT) raised $150 million in an initial public offering (IPO) on Thursday, July 15th 2021. The company issued 6,980,000 shares at $20.00-$23.00 per share.

What is Sight Sciences' stock symbol?

Sight Sciences trades on the NASDAQ under the ticker symbol "SGHT."

When did the company's quiet period expire?

Sight Sciences' quiet period expired on Tuesday, August 24th. Sight Sciences had issued 10,000,000 shares in its initial public offering on July 15th. The total size of the offering was $240,000,000 based on an initial share price of $24.00. During the company's quiet period, insiders and underwriters involved in the IPO were restricted from issuing any research reports for the company because of SEC regulations. Now that the company's quiet period has ended, brokerages that served as underwriters are now able to initiate research on the company.

How do I buy shares of Sight Sciences?

Shares of SGHT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Sight Sciences' stock price today?

One share of SGHT stock can currently be purchased for approximately $28.32.

How much money does Sight Sciences make?

Sight Sciences has a market capitalization of $1.34 billion.

How many employees does Sight Sciences have?

Sight Sciences employs 2,021 workers across the globe.

What is Sight Sciences' official website?

The official website for Sight Sciences is

Where are Sight Sciences' headquarters?

Sight Sciences is headquartered at 4040 CAMPBELL AVE SUITE 100, MENLO PARK CA, 94025.

How can I contact Sight Sciences?

Sight Sciences' mailing address is 4040 CAMPBELL AVE SUITE 100, MENLO PARK CA, 94025. The company can be reached via phone at 877-266-1144 or via email at [email protected]

This page was last updated on 9/16/2021 by Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.